tirzepatide surpass SURPASS-CVOT: Significantly Reduces Major Kidney Events Compared to Dulaglutide in T2D AMRA Used in Tirzepatide Analyses

Annual medical spending attributable to obesity: payer-and service-specific estimates

Bridge Strategies: Switching Between GLP-1 Medications Rather than stopping GLP-1 therapy entirely, many patients benefit from transitioning to a different compound or route that fits their lifestyle better

Tranexamic acid has the best evidence for treating melasma, however it is a thrombophilic drug and thus should be prescribed in select patients

A subset of peptides doesn't work on a cycle at all

Store this medication in a refrigerator between 36F to 46F (2C 8C)

Blood work: the only way to know what you actually need Supplement protocols without blood work are educated guesses